Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT-MG Trial: Tinidazole + Doxycycline for Mycoplasma genitalium
jRCTs031230381Suspended
- Sponsor
- National Center for Global Health and Medicine
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tinidazole and doxycycline in Mycoplasma genitalium infection (Mgen), sponsored by National Center for Global Health and Medicine. Primary endpoint: Treatment Success Rate. Started Oct 2023; status: suspended.
02
Drugs
tinidazoledoxycycline
03
Conditions
Mycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on jRCTs031230381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230381.